Barclays Maintains an 'Underweight' on Omnicare (OCR); Looking Forward to 2012
Tweet Send to a Friend
Barclays maintains an 'Underweight' on Omnicare (NYSE: OCR), PT increased from $27 to $30.
Barclays analyst says, "It is increasingly ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "It is increasingly ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
